Published: December 17, 2009
It’s a company you may never have heard of, but Russia’s Human Stem Cell Institute wants to reopen the country’s IPO market and become a global biotech player. Founder Artur Isaev tells Tim Burke how he plans to do it.
This content is only available to our subscribers.
Please click here for details of subscription plans or to request trial access.